Overview
Steptoe’s Vishal Gupta and Richard Praseuth authored an article titled “Controversy and Guidance for Biosimilar Labeling” for Biotechnology Law Report (Volume 35, Number 4). The article discusses the controversy surrounding the only two biosimilar products to be approved in the United States, and what to expect moving forward.
